CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,620 Cr | ₹5,506 Cr | ₹4,771 Cr | ₹4,057 Cr | ₹3,424 Cr |
What is the latest Sundry Debtors ratio of CIPLA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹5,620 Cr |
| Mar2025 | ₹5,506 Cr |
| Mar2024 | ₹4,771 Cr |
| Mar2023 | ₹4,057 Cr |
| Mar2022 | ₹3,424 Cr |
How is Sundry Debtors of CIPLA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,620 Cr | 2.06 | |
| Mar2025 | ₹5,506 Cr | 15.42 | |
| Mar2024 | ₹4,771 Cr | 17.59 | |
| Mar2023 | ₹4,057 Cr | 18.47 | |
| Mar2022 | ₹3,424 Cr | - | |
Compare Sundry Debtors of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,531.5 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
| MANKIND PHARMA | ₹93,013.6 Cr | -4.9% | -1.9% | -6.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.1% |
-3% |
-15.3% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses